Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD) June 16, 2024
Displaying entries 2176 - 2200 of 6046 in total
Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass Formula ▼
Diacylglycerophosphoinositolglycans LMGP15010192
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-2-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM4(19:2(9Z,12Z)/18:0)
126457560 1524.784083 C70H125O33P
Gangliosides LMSP0601AK02
  • GD3(d18:1/18:0)
  • NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44262045 90240 1471.839882 C70H125N3O29
Diacylglycerophosphoinositolglycans LMGP15010193
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM4(19:2(9Z,12Z)/18:1(9Z))
126457561 1522.768433 C70H123O33P
LMSL03001291
  • 2-O-octadecanoyl,3-O-(2S,4S,6S,8R,10R,12R,14R-heptamethyl)-15-hydroxy-dotriacontanoyl)-2'-sulfotrehalose
  • AC2SGL(18:0/32:0(2Me[S],4Me[S],6Me[S],8Me[S],10Me[R],12Me[R],14Me[R],15OH))
126457732 1264.918527 C69H132O17S
Diacylglycerophosphoinositolglycans LMGP15010162
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1,2-dioctadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM4(18:0/18:0)
126457530 1514.799733 C69H127O33P
Gangliosides LMSP0601DC04
  • Galbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44262575 1398.859888 C69H126N2O26
Gangliosides LMSP0601DG04
  • GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0)
  • KDN-GM2(d18:1/22:0)
44262607 1398.859888 C69H126N2O26
Diacylglycerophosphoinositolglycans LMGP15010194
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-hexadecanoyl-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM5(16:0/14:0)
126457562 1592.758658 C69H125O38P
Diacylglycerophosphoinositolglycans LMGP15010163
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-octadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM4(18:0/18:1(9Z))
126457531 1512.784083 C69H125O33P
Diacylglycerophosphoinositolglycans LMGP15010168
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-octadecenoyl)-2-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM4(18:1(9Z)/18:0)
126457536 1512.784083 C69H125O33P
Gangliosides LMSP0601CI03
  • GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0)
52931291 1427.850052 C69H125N3O27
Gangliosides LMSP0601AM03
  • GM2(d18:1/20:0)
  • GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44262062 141416 1411.855137 C69H125N3O26
Gangliosides LMSP0601EK03
  • NeuAcalpha2-6GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44262830 1411.855137 C69H125N3O26
Gangliosides LMSP0601DD01
  • KDNalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44262580 1476.818813 C69H124N2O31
Gangliosides LMSP0601DF01
  • Galbeta1-3GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0)
  • KDN-GM1(d18:1/16:0)
44262596 1476.818813 C69H124N2O31
Gangliosides LMSP0601EB01
  • KDN-lactotetraosylceramide(d18:1/16:0)
  • KDNalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44262756 1476.818813 C69H124N2O31
Gangliosides LMSP0601EC01
  • KDN(2-6)lactotetraosylceramide(d18:1/16:0)
  • KDNalpha2-6Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44262764 1476.818813 C69H124N2O31
Gangliosides LMSP0601GE01
  • KDNalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44263164 1476.818813 C69H124N2O31
Gangliosides LMSP0601GG01
  • KDN-(2-6)-neolactotetraosylceramide/sialyl-(2-6)-paragloboside(d18:1/16:0)
  • KDNalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44263180 1476.818813 C69H124N2O31
Diacylglycerophosphoinositolglycans LMGP15010169
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-octadecenoyl)-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM4(18:1(9Z)/18:1(9Z))
126457537 1510.768433 C69H123O33P
Diacylglycerophosphoinositolglycans LMGP15010174
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-octadecadienoyl)-2-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM4(18:2(9Z,12Z)/18:0)
126457542 1510.768433 C69H123O33P
Gangliosides LMSP0601AP09
  • GM1(d18:1/14:0)
  • Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/14:0)
70699273 1489.814062 C69H123N3O31
Diacylglycerophosphoinositolglycans LMGP15010175
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-octadecadienoyl)-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM4(18:2(9Z,12Z)/18:1(9Z))
126457543 1508.752783 C69H121O33P
Glycosyldiacylglycerols LMGL05010015
  • 1-(9Z,12Z-octadecadienoyl)-2-(15R-[9Z,12Z-octadecadienoyloxy]-9Z,12Z-octadecadienoyl)-3-(alpha-D-galactosyl-1-6-beta-D-galactosyl)-sn-glycerol
  • DGDG(18:2(9Z,12Z)/18:2(9Z,12Z)[15(R)OH-18:2(9Z,12Z])
52922093 1218.836905 C69H118O17
LMSL03001280
  • 2-O-hexadecanoyl,3-O-(2S,4S,6S,8R,10R,12R,14R,16R-octamethyl)-17-hydroxy-dotriacontanoyl)-2'-sulfotrehalose
  • AC2SGL(16:0/32:0(2Me[S],4Me[S],6Me[S],8Me[S],10Me[R],12Me[R],14Me[R],16Me[R],17OH))
126457721 62113 1250.902877 C68H130O17S

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024